Ombitasvir-Paritaprevir-Ritonavir-Dasabuvir (Viekira Pak)-Induced Lactic Acidosis.

Abstract

OBJECTIVE To report a case series of three patients with hepatitis C virus infection who all presented with severe type B lactic acidosis shortly after starting treatment with ombitasvir-paritaprevir-ritonavir-dasabuvir. DESIGN Case series. SETTING ICU. PATIENTS Three patients, all who had HCV cirrhosis with mild hepatic impairment (Child-Pugh A) and… (More)
DOI: 10.1097/CCM.0000000000002086

Topics

Cite this paper

@article{Oberg2017OmbitasvirParitaprevirRitonavirDasab, title={Ombitasvir-Paritaprevir-Ritonavir-Dasabuvir (Viekira Pak)-Induced Lactic Acidosis.}, author={Catherine L Oberg and Robert J Hiensch and Hooman D. Poor}, journal={Critical care medicine}, year={2017}, volume={45 3}, pages={e321-e325} }